Can Psychedelics Tackle Depression?
Published on January 19, 2018
In recent years, psychedelic drugs have been studied with renewed attention for their potential to help treat depression and anxiety. These drugs include magic mushrooms, ayahuasca, LSD and, to a lesser extent, MDMA, cannabis, and ketamine. A new study suggests that the quality of the trip may predict the degree to which it is beneficial therapeutically. For the study, scientists followed up with participants five weeks after their psychedelic experiments and found that the higher-quality the trip the less depressed people were five weeks later. In their paper which was published in the journal Frontiers in Psychopharmacology the researchers wrote, "This report further bolsters the view that the quality of the acute psychedelic experience is a key mediator of long-term changes in mental health."